Certified by Founder Lodge
Samsara BioCapital
United States - Palo Alto, California
INVESTOR
1 Disclosed Funding Rounds $90,000,000
10 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
N/A
Company | Date | Round | Raised |
---|---|---|---|
SpyGlass Pharma, Inc. | July, 11 ,2023 | Series C | $90,000,000 |
Septerna | July, 18 ,2023 | Series B | $150,000,000 |
Abcuro, Inc | August, 18 ,2023 | Series B | $155,000,000 |
OrsoBio | November, 08 ,2023 | Series A | $60,000,000 |
EyeBio | November, 15 ,2023 | Series A | $65,000,000 |
Seismic Therapeutic | December, 05 ,2023 | Series B | $121,000,000 |
FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
Alumis | March, 07 ,2024 | Series C | $259,000,000 |
Candid Therapeutics | September, 10 ,2024 | Unknown | $370,000,000 |
Enara Bio | October, 04 ,2024 | Series B | $32,500,000 |